Skip to main content
Clinical Trials/NCT01743547
NCT01743547TerminatedNot Applicable

THE EFFECTS OF YOGA ON QUALITY OF LIFE AMONG A POPULATION OF OVARIAN/ FALLOPIAN TUBE/ PRIMARY PERITONEAL CANCER PATIENTS RECEIVING CHEMOTHERAPY: A FEASIBILITY STUDY

Northwestern University1 site in 1 country25 target enrollmentStarted: November 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
25
Locations
1
Primary Endpoint
All patients included in the study will be assessed for response to treatment; the primary outcome is change in QoL domains after yoga class intervention. Planned subgroup analysis: stratification by participation category

Study Overview

Brief Summary

This is a pilot study to establish the feasibility of an eight-week yoga intervention and to estimate the effect size on QoL in female patients with ovarian, fallopian tube and primary peritoneal malignancies receiving chemotherapy for the treatment of primary or recurrent cancer.

Detailed Description

The primary objective of this study was to determine the feasibility of implementing a yoga program among gynecologic cancer patients receiving chemotherapy. The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients. Of 25 consented patients, 16 agreed to participate in the control arm, 9 agreed to participate in the Yoga classes. Three (3) of those 9 changed their minds and withdrew consent. Of the 6 remaining patients, only 3 attended at least 1 of the 8 classes.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Histologically confirmed diagnosis of epithelial ovarian/fallopian tube/primary peritoneal cancer
  • Participant must be age 18 or older
  • Participants must be 6 weeks post-surgery
  • Participant must be currently receiving chemotherapy or beginning a regimen within the next four weeks
  • Participant must be willing to attend the intervention sessions
  • All subjects must have given signed, informed consent prior to registration in the study.

Exclusion Criteria

  • Participant has practiced yoga more than 4 times in the last year
  • Participant has a surgical procedure scheduled during the 8 weeks that they would be part of the intervention
  • Participant has an ECOG performance status less than or equal to two

Arms & Interventions

No Intervention; Arm A; Control Group

No Intervention

24 subjects who declined yoga but agreed to data collection

Active Comparator; Arm B; Intervention Group

Active Comparator

24 subjects participating in 8 weeks of Yoga and agreed to data collection

Intervention: Yoga (Other)

Outcomes

Primary Outcomes

All patients included in the study will be assessed for response to treatment; the primary outcome is change in QoL domains after yoga class intervention. Planned subgroup analysis: stratification by participation category

Time Frame: Total study duration is anticipated to require approximately 24 weeks

Pilot study to establish the feasibility of a yoga program \& estimate the effect size of a yoga intervention on QoL in patients with epithelial ovarian, fallopian tube \& primary peritoneal cancer receiving chemotherapy for the treatment.The goal for each individual question on the questionnaire is to have a 90-95% completion rate. The validated instruments: FACT-O, FACIT-F, FACIT-Sp, CES-D, PROMIS, and PSQI will be scored according to their respective guidelines, and then paired t-tests will be used to compare the pre-yoga and post-yoga means. Participant completion will be recorded in one of three ways: complete, meaning the participant attended 5 or more yoga sessions and filled out all the required surveys; partially complete, meaning the participant attended 1-4 sessions, and/or did not fill out all the required surveys; and did not participate, meaning the participant attended 0 sessions. All analyses will be stratified for participation category.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nikki Neubauer

Assistant Professor in Obstetrics and Gynecology

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials